Carotid artery stenting (CAS) and carotid endarterectomy (CEA) are procedures that can restore patency and reduce the long-term risk of stroke. Both CAS and CEA have become common procedures in…
read moreThe landscape of paediatric multiple sclerosis (MS) is rapidly evolving. In her presentation titled ‘Pediatric MS – Current treatment strategies and future directions’ at the MS State of the Art…
read moreThe life expectancy in multiple sclerosis (MS) continues to increase and is now comparable to that of the general population.1 This increase comes with the challenge of learning how to…
read moreAutologous hematopoietic stem cell transplantation (aHSCT) has been used in the treatment of multiple sclerosis (MS) since 1995 and was approved in Switzerland in June 2018. In their presentation ‘Stem…
read moreThe repertoire of available multiple sclerosis (MS) disease modifying therapies (DMTs) is constantly growing. In recent years, there have been several new DMTs that have entered the market. In his…
read moreDuring the current coronavirus 2019 disease (COVID-19) pandemic, research is being developed and disseminated at an accelerated pace.1 The constant influx of data can be of varying quality and reliability…
read moreThere has been increasing worry about possible cognitive consequences related to COVID-19 and recent case studies have revealed neurological problems in severely affected patients.1 Growing evidence shows that certain individuals…
read moreIn a guest post on “The MS Blog,” Dr Oliver Findling summarised a recent study on which he was the principal investigator: Humoral Immune Response after the Third SARS-CoV-2 mRNA…
read moreProf. Mary Reilly is a consultant neurologist at the National Hospital for Neurology and Neurosurgery and a professor of clinical neurology, heading the division of clinical neurology in the Institute…
read moreThe CENTAUR phase 2, randomised, placebo-controlled trial included patients with amyotrophic lateral sclerosis (ALS) who received a fixed dose formulation of sodium phenylbutyrate-taurursodiol (PB-TURSO). The trial showed results of a…
read more